0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Chemotherapy

Not currently available

Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents (Hardcover) Loot Price: R4,501
Discovery Miles 45 010
Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents (Hardcover): Paul J. Smith, Eddy W. Yue

Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents (Hardcover)

Paul J. Smith, Eddy W. Yue

Series: Enzyme Inhibitors Series

 (sign in to rate)
Loot Price R4,501 Discovery Miles 45 010 | Repayment Terms: R422 pm x 12*

Bookmark and Share

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

One of the few books to cover all aspects of cyclin-dependent kinases (CDKs), Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents provides an overview of CDKs as molecular and functional entities, their involvement in different disease processes, and their potential for pharmacological modulation. With contributions from the top international researchers in the field, the book takes a contemporary approach to study the importance of rational drug design and knowledge-based therapeutics in relation to CDKs.

The first two sections of the book discuss the integration of cell cycle control pathways, opportunities for targeting, targets of inhibitors, and the evaluation of CDK inhibitors, exploring topics such as the "in vivo "function of CDKs in normal homeostasisand tumor development and the structural biology of CDKs. The third section examines the design, development, and chemistry of small molecule CDK inhibitors, with discussions ranging from the early-stage discovery ofnew chemical entities with a capacity to inhibit CDKs to late-stage compounds in clinical development. The final section assesses the current status of CDK inhibitors in clinical trials, the therapeutic deployment challenges of small molecule inhibitors, and the future development of CDK inhibitors as anticancer agents.

The field of drug development is at a critical point in terms of understanding the availability, advantages, and drawbacks of CDKs as therapeutic targets for small molecules. Providing the most up-to-date, in-depth coverage available in a single volume, Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents surveys the success of the agents developed thus far, the possibility of newroutes to more selective inhibitors, and the growing appreciation of critical, therapeutic issues.

General

Imprint: Crc Press
Country of origin: United States
Series: Enzyme Inhibitors Series
Release date: October 2006
First published: October 2006
Editors: Paul J. Smith • Eddy W. Yue
Dimensions: 234 x 156 x 30mm (L x W x T)
Format: Hardcover
Pages: 448
ISBN-13: 978-0-8493-3774-1
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Chemotherapy
LSN: 0-8493-3774-7
Barcode: 9780849337741

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners